Herbal-Review.com

Independent honest reviews of most effective natural herbal supplements

LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase II Clinical Program

by @ 7:35 am on May 17, 2008.

LifeCycle Pharma A/S (OMX:LCP) announced positive results from the company’s Phase II clinical program with LCP-AtorFen, a fixed-dose combination product of atorvastatin and fenofibrate for the treatment of mixed dyslipidemia. LCP-AtorFen is a convenient single tablet with a once-daily dosage profile and is without food effect.
“The Phase II clinical program confirmed that LCP-AtorFen was […]

[link]

05/16/2008: Gene Variant Boosts Risk of Severe Diabetic Eye, Kidney Diseases

06/02/2008: Combo Therapy Knocks Out Melanoma Tumors (HealthDay)

05/09/2008: Rickets on the Rise

06/10/2008: Milan clinic probed for alleged needless surgery (AP)

06/20/2008: FDA inspectors head to Fla., Mexico in salmonella probe (AP)

The URI to TrackBack this entry is: http://herbal-review.com/2008/05/17/lifecycle-pharma-announces-positive-data-from-lcp-atorfen-phase-ii-clinical-program/trackback/

Please healthy :)

You must be logged in to post a comment.

|No results yet!